Topics

Companies Related to "Alzheimer disease brain inflammation" [Most Relevant Company Matches] [Advanced Search Results] RSS

12:52 EDT 20th September 2019 | BioPortfolio

Here are the most relevant search results for "Alzheimer disease brain inflammation" found in our extensive corporate database of over 50,000 company records.

Showing "Alzheimer disease brain inflammation" Companies 1–25 of 3,300+

Relevant

The Alzheimer's Association

The Alzheimer's Association is the leading voluntary health organization in Alzheimer care, support and research. Our mission is to eliminate Alzheimer's disease through the advancement of research; to provide and enhance care and support for all affected; and to reduce the risk of dementia through the promotion of brain health. Our vision is a world without Alzheimer's. For more informatio...


NeuroMedix

NeuroMedix is a pharmaceutical company focused on the development of therapeutic agents for the treatment of degenerative and inflammatory diseases of the central nervous system, such as Alzheimer's disease and multiple sclerosis. Our therapeutic candidates are based on research from a team of leading experts in the field of neuroinflammation.In pre-clinical studies, our candidates have proven to ...

The Alzheimer’s Association

The Alzheimer’s Association is the world’s leading voluntary health organization in Alzheimer care, support and research. Its mission is to eliminate Alzheimer’s disease through the advancement of research; to provide and enhance care and support for all affected; and to reduce the risk of dementia through the promotion of brain health. Learn more ...


Arizona Alzheimer's Consortium

The Arizona Alzheimer's Consortium is a laboratory without walls designed to leverage the strengths of its seven member institutions to promote the scientific understanding of Alzheimer's disease. The Consortium is attacking Alzheimer's disease by combining breakthroughs in genomic medicine and cutting-edge research with data from sophisticated brain imaging programs and advanced clinical trials t...

Ebixa

Ebixa is an effective, safe and well tolerated therapy, that helps overcome the everyday challenges in Alzheimer’s disease, easing the lives of both patients and their carers. Ebixa is indicated for the treatment of moderate to severe Alzheimer’s disease. Ebixa is a specific, uncompetitive NMDA-receptor antagonist, with a novel mechanism of action that targets the glutamatergic signalling in ...

Banner Alzheimer's Institute

Banner Alzheimer's Institute (BAI) is a treatment and research facility dedicated to helping patients with memory and thinking problems. It offers clinical care for patients; provides education, referral and support services for families and caregivers; and conducts leading-edge brain-imaging, clinical trials, brain imaging and genetics studies. The Institute is devoted to finding effective Alzhei...

Janssen Alzheimer Immunotherapy

Alzheimer's disease (AD), the most common form of dementia, is a fatal, degenerative brain disease that gradually destroys a person's memory and ability to learn, reason, make judgments, communicate and carry out daily activities, such as bathing and eating. As AD progresses, individuals may also experience changes in personality and behavior, such as anxiety, suspiciousness or agitation, delusion...

Mind-NRG

Mind-NRG is devoted to the development of NRG-101 in psychiatric and neurologic diseases. NRG-101 is a neurotrophic factor with disease modifying potential that naturally crosses the blood-brain barrier through a receptor-mediated transport to reach its target in the brain. Currently at the pre-clinical stage, NRG-101 is being developed to treat d...

Alzheimer's Research Foundation

The Fisher Center for Alzheimer's Research Foundation is a leading source of funding for Alzheimer's research. It serves Alzheimer's patients and their families to understand the causes of Alzheimer's, to discover a cure, and to improve the lives of people with the disease. Nobel laureate Dr. Paul Greengard directs the Foundation's team of internationally renowned scientists, who have been at th...

CorTechs Labs

CorTechs Labs develops and markets breakthrough medical device software solutions capable of automatically segmenting and quantifying brain structures, making quantitative analysis of the human brain a routine part of clinical practice. CorTechs Labs’ cutting-edge brain imaging analysis provides neurologists, radiologists and clinical researchers worldwide with a convenient and cost-effectiv...

Brain Injury Research Institute

The Brain Injury Research Institute is a center for the study of traumatic brain injuries and prevention, which is affiliated with the Blanchette Rockefeller Neuroscience Institute at West Virginia University. The purpose of the Institute is to study the short and long-term impact of brain injuries in order to better understand the impact of concussions, the development of chronic traumatic enceph...

Alzheimer's Research and Prevention Foundation

The Alzheimer's Research and Prevention Foundation (ARPF) is a non-profit organization dedicated to reducing the incidence of Alzheimer's disease by conducting clinical research and providing educational outreach about the lifestyle changes that can help prevent Alzheimer's disease. For more information, please visit the Alzheimer's Research and Prevention Foundation at www.alzheimersprevention.o...

Alzheimer’s Association, New York City Chapter

Alzheimer’s disease is one of the nation’s largest public health crises. It is the fifth leading cause of death in California and the only leading cause of death that cannot be prevented, cured or even slowed. 630,000 people in California are currently living with Alzheimer’s disease, and more than 1.6 million Californians provide unpaid care for ...

TREVENTIS Corporation

TREVENTIS is headquartered in Southeastern Pennsylvania and has research operations in Halifax, Nova Scotia, Canada. The company is focused on the discovery and early stage development of disease- modifying small molecule drugs for Alzheimer’s and other protein misfolding diseases such as Parkinson’s and Huntington’s diseases. In addition to its ...

Alzheimer's Foundation International

The Alzheimer's Foundation International (AFI) is working toward collaboratively setting a paradigm of quality care for individuals with the disease and their families by raising awareness of Alzheimer's disease and related dementias, providing education, and establishing programs and services that can be replicated in countries around the globe. Currently, AFI's member organizations are the Alzhe...

Alzheon, Inc.

Alzheon, Inc., is a clinical-stage biotechnology company focused on brain health, memory and aging, developing innovative treatments for Alzheimer’s disease and other neurodegenerative disorders. Alzheon pursues drug development programs that have previously been tested in extensive efficacy studies in Alzheimer’s disease patients and where new i...

Neuronascent, Inc

Neuronascent began operations in a fully functional cell culture facility in Maryland. Neuronascent is in the process of developing small-molecule therapeutics for Alzheimer’s disease and depression as the main indications for its “neurogenesis” program. An orally-active, neurogenic agent could promote the formation of new neurons in key areas of the brain, replace damaged neurons, and reduc...

Neuronix Ltd.

Established in 2008, Neuronix has developed a non-invasive technology-based treatment of brain conditions and their related symptoms, with a focus on Alzheimer's Disease (“AD”). Neuronix's proprietary (patent pending) technology is based on the concurrent use of non-invasive Transcranial Magnetic Stimulations (“TMS”) to specific regions...

Neurodyn Cognition Inc.

NCI is a private Canadian biotech company developing Memogain, a patented prodrug of an approved treatment for Alzheimer’s disease, galantamine (Reminyl®). Memogain’s intranasal administration achieves higher dose levels, with significantly greater brain bioavailability, while avoiding the compliance impairing gastro-intestinal adverse effects...

EXPERT BIOMED, INC

Expert BioMed offers a service to pharmaceutical companies providing screening of potential drugs on Alzheimer's disease cell and animal models designed and maintained in the company and data interpretation service in addition to the Expert BioMed systems and platform for new drug development. Expert BioMed offers new monoclonal and polyclonal antibodies, recombinant proteins and peptides as bioma...

Panacea Pharmaceuticals

Panacea Pharmaceuticals, Inc. focuses on developing and utilizing protein-based technologies to detect and identify changes associated with and involved in diseases of the central nervous system such as Alzheimer's disease, brain tumors, transmissible spongiform encephalopathies, and Lewy Body diseases such as Parkinson's disease. Changes in disease-relevant proteins by altered expression, post-tr...

Tetra Therapeutics

Tetra Therapeutics is a clinical stage biotechnology company developing a portfolio of therapeutic products that will bring clarity of thought to people suffering from Fragile X Syndrome, Alzheimer's disease, traumatic brain injury, and other brain disorders. Tetra uses structure-guided drug design to discover mechanistically novel, allosteric inhibitors of phosphodiesterase 4 (PDE4), an enzyme f...

MS Central Support

Multiple Sclerosis a life-long chronic disease. Multiple Sclerosis signifies the following: "Multiple" refers to the many areas of inflammation and demyelination that occurs over time. "Sclerosis" means scarring. MS is an autoimmune disease. In MS, the immune system attacks the body's myelin. Myelin is a fatty protein that acts as an insulating matter for nerves. When myelin becomes damaged (demye...

M3 Biotechnology, Inc.

M3 Biotechnology is a clinical stage company with a novel platform of disease-modifying regenerative therapies particularly relevant to neurodegenerative diseases, with a focus on Alzheimer’s. M3’s lead asset, NDX-1017, modifies growth factor systems and is advanced as a first-in-class, disease-modifying treatment with the potential to restore lo...

Cortex Pharmaceuticals, Inc.

Cortex, located in Irvine, California, is a neuroscience company focused on novel drug therapies for treating psychiatric disorders, neurological diseases and sleep apnea. Cortex is pioneering a class of proprietary pharmaceuticals called AMPAKINE® compounds, which act to increase the strength of signals at connections between brain cells. The loss of t...


More From BioPortfolio on "Alzheimer disease brain inflammation"

Quick Search

Corporate Database Quicklinks